These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 683623)

  • 1. Use of hPL in the diagnosis of intrauterine growth retardation.
    Gohari P; Hobbins JC; Berkowtiz R
    Obstet Gynecol; 1978 Jul; 52(1):127-8. PubMed ID: 683623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The value of fetal blood flow measurements in intrauterine growth retardation in comparison with E3 and human placental lactogen determinations].
    Spernol R; Hecher K; Szalay S
    Geburtshilfe Frauenheilkd; 1989 May; 49(5):463-5. PubMed ID: 2661312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human placental lactogen: a predictor of perinatal outcome?
    Zlatnik FJ; Varner MW; Hauser KS
    Obstet Gynecol; 1979 Aug; 54(2):205-10. PubMed ID: 460755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The value of biochemical parameters in the prenatal diagnosis of intrauterine growth retardation].
    Holtorff J; Beutner M; Schollberg K
    Acta Univ Palacki Olomuc Fac Med; 1981; 101():15-21. PubMed ID: 6211043
    [No Abstract]   [Full Text] [Related]  

  • 5. Oxytocinase and human placental lactogen for the prediction of intrauterine growth retardation.
    Hensleigh PA; Cheatum SG; Spellacy WN
    Am J Obstet Gynecol; 1977 Nov; 129(6):675-8. PubMed ID: 920768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Serum HPL, total estrogen excretion and serum oxytocinase in intrauterine retardation. Results of 3 evaluation procedures].
    Kyank HR
    Zentralbl Gynakol; 1983; 105(10):635-41. PubMed ID: 6880465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A pregnancy without detectable human placental lactogen (hPL)].
    Trapp M; De Wilde R; Holzgreve W; Stals HJ; Bohnet HG
    Zentralbl Gynakol; 1987; 109(2):130-3. PubMed ID: 3554836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive value of human placental lactogen determinations in pregnancy.
    Harrigan JT; Langer A; Hung CT; Pelosi MA; Washington E
    Obstet Gynecol; 1976 Apr; 47(4):443-5. PubMed ID: 1256728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Urinary estriol, serum HPL and intrauterine retardation of fetal growth].
    Iarŭkov A
    Akush Ginekol (Sofiia); 1987; 26(1):20-4. PubMed ID: 3592103
    [No Abstract]   [Full Text] [Related]  

  • 10. [Prognostic value of determining HPL for threatened fetuses during risk pregnancies].
    Simko J; Machánova Y
    Cesk Gynekol; 1982 Sep; 47(8):571-5. PubMed ID: 7139742
    [No Abstract]   [Full Text] [Related]  

  • 11. [Biparietal measurements, human placental lactogenic hormone and estradiol in the evaluation of the fetus].
    Berendtsen H; Klünder KB; Nørskov O
    Ugeskr Laeger; 1985 Sep; 147(38):2984-6. PubMed ID: 3907070
    [No Abstract]   [Full Text] [Related]  

  • 12. Study on blood level of human placental lactogen in abnormal pregnancy.
    Samanta B; Dutta GP
    J Indian Med Assoc; 1989 Sep; 87(9):205-7. PubMed ID: 2621369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The value of biochemical parameters in the prenatal diagnosis of intrauterine fetal retardation].
    Holtorff J; Beutner M; Schollberg K
    Acta Univ Palacki Olomuc Fac Med; 1981; 101():15-21. PubMed ID: 6242686
    [No Abstract]   [Full Text] [Related]  

  • 14. [The placenta. Ultrasonic and hormonal changes in fetal growth retardation].
    Ruseva R; Katsulov A; Marinov B; Atanasov B; Milkov V
    Akush Ginekol (Sofiia); 1985; 24(1):16-9. PubMed ID: 3893186
    [No Abstract]   [Full Text] [Related]  

  • 15. Hormonal placental functions and intrauterine growth retardation in patients with positive contraction stress tests.
    Odendaal HJ; Malan C; Oosthuizen J
    S Afr Med J; 1981 May; 59(23):822-4. PubMed ID: 7233299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maternal serum concentrations of human placental lactogen, estradiol and pregnancy specific beta 1-glycoprotein and fetal growth retardation.
    Gardner MO; Goldenberg RL; Cliver SP; Boots LR; Hoffman HJ
    Acta Obstet Gynecol Scand Suppl; 1997; 165():56-8. PubMed ID: 9219458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Fetal intrauterine growth retardation: possibilities of antepartum diagnosis].
    Benz J
    Schweiz Rundsch Med Prax; 1987 Mar; 76(14):366-74. PubMed ID: 3296093
    [No Abstract]   [Full Text] [Related]  

  • 18. Further investigation on the predictive value of human placental lactogen in high-risk pregnancies.
    Granat M; Sharf M; Diengott D; Spindel A; Kahana L; Elrad H
    Am J Obstet Gynecol; 1977 Nov; 129(6):647-54. PubMed ID: 920766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin II (Ang II) evoked secretion of the human placental lactogen (HPL) in intrauterine growth retardation: examination of the relationship with Ang II receptor type 1 (AT1) expression.
    Szukiewicz D; Maslinska D; Gujski M; Pyzlak M; Klimkiewicz J; Stelmachow J
    Int Immunopharmacol; 2008 Feb; 8(2):177-81. PubMed ID: 18182223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Human placental lactogen in the blood in fetal growth retardation].
    Bila S; Sulović V; Genbacev O
    Srp Arh Celok Lek; 1980 Apr; 108(4):317-24. PubMed ID: 7233269
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.